NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 19.4
(-8.92%)
TWD 19.4
(-8.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 76.96 Million TWD | -35.32% |
| 2022 | 118.98 Million TWD | -11.79% |
| 2021 | 134.89 Million TWD | -21.29% |
| 2020 | 171.38 Million TWD | 6.32% |
| 2019 | 161.19 Million TWD | 220.65% |
| 2018 | 50.27 Million TWD | 69.56% |
| 2017 | 29.64 Million TWD | 26.93% |
| 2016 | 23.35 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 36.01 Million TWD | -21.86% |
| 2024 Q2 | 36.01 Million TWD | 0.0% |
| 2023 Q2 | 30.87 Million TWD | 71.26% |
| 2023 FY | 76.96 Million TWD | -35.32% |
| 2023 Q3 | 25.65 Million TWD | -16.9% |
| 2023 Q1 | 18.03 Million TWD | -68.7% |
| 2023 Q4 | 46.08 Million TWD | 79.6% |
| 2022 Q2 | 61.38 Million TWD | 0.0% |
| 2022 Q4 | 57.6 Million TWD | 0.0% |
| 2022 FY | 118.98 Million TWD | -11.79% |
| 2021 Q2 | 37 Million TWD | 0.0% |
| 2021 Q4 | 97.88 Million TWD | 0.0% |
| 2021 FY | 134.89 Million TWD | -21.29% |
| 2020 FY | 171.38 Million TWD | 6.32% |
| 2020 Q4 | 68.68 Million TWD | 0.0% |
| 2020 Q2 | 102.7 Million TWD | 0.0% |
| 2019 Q4 | 90.58 Million TWD | 0.0% |
| 2019 FY | 161.19 Million TWD | 220.65% |
| 2018 FY | 50.27 Million TWD | 69.56% |
| 2017 FY | 29.64 Million TWD | 26.93% |
| 2016 FY | 23.35 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -23293.009% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 80.881% |
| Level Biotechnology Inc. | 219.54 Million TWD | 64.944% |
| Sagittarius Life Science Corp | 71.47 Million TWD | -7.675% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 947.144% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 65.83% |
| GlycoNex Incorporation | 995 Thousand TWD | -7634.975% |
| VBI | 16.42 Million TWD | -368.629% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -179.013% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 61.219% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -14672.169% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 35.816% |
| Visgeneer Inc. | 67.48 Million TWD | -14.05% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 120.513% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 94.522% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 46.77% |
| Neith Corporation | 18.01 Million TWD | -327.121% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 66.57% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -238.418% |
| Enimmune corporation | -23.37 Million TWD | 429.282% |
| TaiRx, Inc. | 2.43 Million TWD | -3055.515% |
| CHO Pharma, Inc. | -28.27 Million TWD | 372.156% |
| EirGenix Inc. | 236.74 Million TWD | 67.491% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 26.246% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 73.045% |
| Lin BioScience, Inc. | -17.92 Million TWD | 529.313% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 14.121% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | 4.656% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -7006.464% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 42.518% |
| RBC Bioscience Corporation | 72.89 Million TWD | -5.581% |
| BiOptic Inc. | 152.74 Million TWD | 49.613% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -85414.444% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -1054.387% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2843.136% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 88.048% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 741.251% |
| NaviFUS Corp. | 11.82 Million TWD | -550.74% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 20.471% |
| Sinew Pharma Inc. | -28.98 Million TWD | 365.527% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -24488.818% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 80.389% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -85.538% |
| AP Biosciences Inc | 32.25 Million TWD | -138.623% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 87.533% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -1359.291% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 75.528% |
| Intech Biopharm Corporation | -163.99 Million TWD | 146.93% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | -136.358% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 2010.226% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 890.256% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 84.123% |
| TCI GENE Inc. | 174.61 Million TWD | 55.925% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 563.605% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 856.542% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | -0.791% |
| PharmaEngine, Inc. | 718.97 Million TWD | 89.295% |
| Savior Lifetec Corporation | 220.94 Million TWD | 65.167% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 31.09% |
| OBI Pharma, Inc. | -73.49 Million TWD | 204.716% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 44.579% |
| Acepodia, Inc. | 16.59 Million TWD | -363.828% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -180.181% |